Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Wu, Zheng  [Clear All Filters]
Journal Article
Qin T, Chen K, Li J, Qian W, Xiao Y, Wu E, Ma J, Chen Z, Wang Z, Ma Q, et al. Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Biomed Pharmacother. 2022;148:112713.
Brasier AR, Zhao Y, Spratt HM, Wiktorowicz JE, Ju H, L Wheat J, Baden L, Stafford S, Wu Z, Issa N, et al. Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. PLoS One. 2015;10(11):e0143165.
Ge X, Liu X, Lin F, Li P, Liu K, Geng R, Dai C, Lin Y, Tang W, Wu Z, et al. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer. Oncotarget. 2016.
Li R, Duan W, Ma J, Lei J, Xu Q, Jiang Z, Nan L, Li X, Wang Z, Huo X, et al. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Oncotarget. 2014.
Zhou C, Qian W, Ma J, Cheng L, Jiang Z, Yan B, Li J, Duan W, Sun L, Cao J, et al. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif. 2018:e12514.
Xu Q, Zong L, Chen X, Jiang Z, Nan L, Li J, Duan W, Lei J, Zhang L, Ma J, et al. Resveratrol in the treatment of pancreatic cancer. Ann N Y Acad Sci. 2015.